Clinical Trial Update: Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study [Phase 2]

View source ↗

Summary

A completed Phase 2 trial comparing Cyclosporine A to intravenous Cyclophosphamide for lupus nephritis in systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Cyclophosphamide (intravenous) (cyclophosphamide)
• Cyclosporine A (cyclosporine)

Snippet

Sponsor: Institute of Rheumatology, Prague | Conditions: Systemic Lupus Erythematosus, Lupus Nephritis | Phase 2 | Status: COMPLETED